Neuroblastoma is the most common extracranial solid malignant tumour of children. It arises from the embryonal neural crest tissue and affects approximately 1 in 10,000 individuals (Donner, 1991) . The prognosis in neuroblastoma is variable, and many studies have been carried out which correlate clinical and biological factors with outcome (Evans et al., 1987; Oppedal et al., 1988) . Prognostic variables include age, stage, histopathological appearance, partial monosomy of lp (Christiansen & Lampert, 1988) , ploidy, N-myc amplification (Bourhis et al., 1991) and nerve growth factor receptor expression (Brodeur, 1993) . In addition, serum concentrations of ferritin, neuron-specific enolase and lactate dehydrogenase have been found to correlate with clinical outcome (Silber et al., 1991) .
It now seems likely that neuroblastoma patients may be classified in two therapeutic categories according to biological features (Woods et al., 1992) . Favourable prognosis in neuroblastoma is associated with young age (less than 1 year) and early stage (1 or 2a), triploid karyotype, lack of lp abnormalities and absence of N-myc gene amplification. Patients with these features have an excellent outcome with little or no therapy. Unfavourable prognosis is associated with older age, advanced stage (2b, 3 or 4), pseudodiploid and tetraploid karyotypes, lp deletions and N-myc amplification. In these patients the outcome is relatively poor despite aggressive multiagent chemotherapy and, in some cases, marrow ablative treatment with bone marrow transplantation. Ultimately it should be possible to use the most discriminating of these factors to define international criteria for the diagnosis and staging of neuroblastoma and its response to treatment (Brodeur et al., 1993) .
N-myc, a proto-oncogene located at 2p23-24 (Schwab et al., 1984) , may be amplified up to 500 times in neuroblastoma, usually as double minutes or as chromosomally integrated homogeneously staining regions. N-myc amplification has been shown to correlate strongly with rapid tumour progression and poor prognosis independent of the other poor prognostic factors with which it is frequently associated. However, amplification is not found in all poorrisk neuroblastomas: it is present in about 40% of stage 4 tumours. Similarly, deletions of chromosome lp and pseudodiploidy have been found to be independent markers of poor prognosis (Hayashi et al., 1989) . It is now thought that del(lp) occurs less frequently than originally described, because early studies concentrated on advanced tumours and established cell lines, in which more than 70% of the tumours had deletions (Brodeur & Fong, 1989) . This abnormality is much less commonly found in stage 1 and 2 tumours (Hayashi et al., 1989) . The consensus deletion has been mapped to lp36.1-2 (Weith et al., 1989) , which may be the site of a tumour-suppressor gene, or anti-oncogene, important in neuroblastoma (Schwab, 1991) .
The presence of del(lp), N-myc amplification, or pseudodiploid or tetraploid karyotype, can be used at diagnosis to identify patients who will do badly despite an apparently favourable clinical picture. Intensive treatment can then be specifically given to this subgroup of patients (Look et al., 1991) . A relevant and crucial observation has been that the N-myc status of a particular tumour does not evolve or regress during the course of the disease. One study by Brodeur and Fong (1989) (Christiansen et al., 1992) . This technique can be applied to nuclear preparations from cultured cells, from collagenase disaggregated tissue, and from specially treated paraffin sections (Stock et al., 1993) .
We report a new, rapid and direct method for the determination of N-myc amplification, chromosome 1 copy number, presence of lp deletion and ploidy using fluorescence in situ hybridisation (FISH) on tumour imprints made directly onto glass slides, and on standard bone marrow smears.
Materials and methods
Primary neuroblastoma samples were obtained by needle or Trucut biopsy or open surgery and fresh tissue from all samples was sent to the Royal Victoria Infirmary, Newcastleupon-Tyne, UK, for N-myc Southern blotting, culture and karyotyping, under the aegis of the Neuroblastoma Committee of the United Kingdom Children's Cancer Study Group (UKCCSG). In each case the diagnosis conformed with internationally agreed criteria (Brodeur et al., 1993) and histological sections were reviewed by the UKCCSG's histological review panel. Imprints were made directly onto silane-coated slides using a dry, blood-free, newly cut surface of the fresh, unfixed biopsy material. This was done as soon as possible after removal of the tumour from the patient, either at the hospital of origin or after transport in tissue culture medium (RPMI-1640) to this laboratory. When possible, depending on sample size, at least six imprints were made of each specimen. Slides made elsewhere were sent, air dried and unfixed, by first class mail. Bone marrow slides were also sent when an aspirate had been performed. Dry slides were then fixed in 100% methanol for a minimum of 10 min, dried, and examined by phase-contrast microscopy to ascertain the amount of debris present and the number of tumour nuclei in the preparation. Slides were then washed briefly in 70% glacial acetic acid to remove debris and cytoplasm, and immediately rinsed again in methanol. Further microscopic examination showed whether the acetic acid treatment had been adequate. If necessary this was cautiously repeated: on some slides 100% acetic acid was used. Slides were finally dehydrated through an ethanol series. Before fluorescence in situ hybridisation the slides were baked at 65°C for about 4 h.
Neuroblastoma lines PCF, IMR32 and Kelly (obtained from J. Kemshead, ICRF, Bristol, UK) were cultured in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal calf serum (FCS) and 1% non-essential amino acid supplement at 37°C with 10% carbon dioxide. To obtain metaphase spreads the cells were incubated for 1-2 h with colcemid at 0.04 jIg ml-', detached with trypsin and resuspended in 75 mM potassium chloride for 10 min. Fixation was in 3:1 methanol-glacial acetic acid and nuclei were dropped onto cleaned glass slides.
Synchronised interphase preparations were obtained from the neuroblastoma lines and from human foreskin fibroblasts, cultured as above, by adding thymidine at 300 lag ml-' to block confluent cell cultures. This was washed out after 16 h and the cells left a further 8 h before harvesting as described.
DNA probes A plasmid probe for N-myc, pNb-9, consisting of a genomic HindIII fragment of 15 kb in pBR322, was obtained from M. Schwab, Heidelberg, Germany. The probe pUCI.77 is a satellite III repetitive DNA located in the heterochromatic region of chromosome 1 (lql2) (Cooke & Hindley, 1979) . CT4-1 is a 35 kb cosmid clone isolated from a library using a plasmid-subcloned DNA probe pl-24, also from M. Schwab, which maps close to the consensus deletion at lp36.1-2. A centromere probe p4.4 for chromosome 8 (M. Rocchi & A. Baldini, unpublished data) was used as a control and to obtain additional information about ploidy. DNA was labelled by nick translation with biotin-1 -dATP (BRL Bionick kit) according to the instructions of the supplier. The probes were purified through a Sephadex G50 column to remove free nucleotides and precipitated with salmon sperm DNA and Escherichia coli tRNA prior to use for in situ hybridisation.
In situ hybridisation Hybridisation and detection were performed according to our modification of the technique described by Pinkel et al. (1986) and Taylor et al. (1993) . Nuclei on slides were denatured immediately before hybridisation in 70% formamide, 2 x SSC (1 x SSC is 0.15 M sodium chloride, 0.01 5 M sodium citrate), pH 7, at 37C for 3 min and then dehydrated through an ethanol series of 70%, 95% and absolute ethanol for 3 min each.
An 80 ng aliquot of each biotinylated cosmid probe and 60 ng of each centromere probe were mixed separately with 3jig of Cot-l DNA (Gibco BRL) to reduce signal from repetitive sequences. The probe/competitor mixtures were vacuum dried under ethanol and resuspended in 11 jil of hybridisation mix (10% dextran sulphate, 2 x SSC, 50% formamide, 1% Tween 20, pH 7). These were denatured for 5 min at 75°C, chilled on ice and allowed to reanneal for up to 3 h at 37°C before being applied to denatured slides. Separate imprints of the tumours were used for each of pNb-9, pUCI.77, CT4-1 and p4.4. Hybridisation was performed overnight at 37°C under sealed coverslips.
Probe detection
The slides were washed first in 50% formamide, 2 x SSC, pH 7, followed by 2 x SSC, pH 7, three times each at 42°C, then once in 4 x SSC, 0.05% Tween 20, pH 7 (SSCT). Slides were preincubated with low-fat dried milk (Marvel) (SSCTM). Detection of the biotinylated signal was carried out by incubation with 5 LIml-' fluorescein isothiocyanate (FITC)-conjugated avidin DCS (Vector Labs) in SSCTM for 30-40 min at 37°C. The signal was amplified by incubation with 5 jig ml-' biotinylated anti-avidin for 30 min and a second round of FITC-avidin DCS. Between the incubations the slides were washed three times in SSCT at room temperature for 3 min. Finally they were washed in phosphate-buffered saline and dehydrated with ethanol.
Nuclei were counterstained with 0.5 jlg ml-' propidium iodide in Citifluor antifade solution (Citifluor, London, UK). Images were photographed using a Zeiss Axiophot microscope with Zeiss filter set 9.PRO and Fujicolor 400 ASA print film.
Evaluation of FISH results
Each of the four probes was hybridised onto separate imprints or bone marrow smears. If both imprints and smears were available for an individual patient then all four probes were hybridised to both sets of slides. An extra slide was stained with Giemsa or May-Grunwald-Giemsa (MGG) so that a parallel assessment of morphology could be made allowing identification of tumour cells.
The neuroblastoma cells in these preparations were frequently single, but often there was nuclear clumping. It was necessary to include clumped nuclei in the study, but if the nuclei were overlapping, as opposed to adjacent, they were excluded. In some parts of the slides red blood corpuscles were still present. These take up FITC non-specifically, so when they were overlapping a tumour cell that cell had to be excluded. The signals counted in each nucleus were of equal intensity to each other, though there was slight variation from cell to cell. Minor hybridisation spots and background fluorescence were discounted. Signals had to be completely separate from one another to be included; paired spots close together were counted as one signal.
Inevitably, given the material from which these preparations were made, there was an admixture of tumour cells and normal stromal or haemopoietic cells on each slide which varied from one area to another. It was meaningless, therefore, to include a preset number of random nuclei and calculate average signal numbers. Only the cells which were considered most likely to be tumour cells, after examination of the Giemsa-stained slide of the same preparation, were included. In fact, the proportion of non-tumour cells in the tumour imprints was very low (<15%), whereas in some bone marrow smears it was considerably higher. However there was no difficulty in deciding which cells to include.
In all samples there were nuclei which did not react with the DNA probes, and also there were infrequent cells with three or more signals. Control experiments were carried out with both centromere probes, CT4-1 and pNb-9, using human foreskin fibroblast (HFF) nuclei and examining 600 nuclei for signal number. In the tumour imprints and bone marrow smears at least 50, and preferably 100, nuclei were examined which were believed to be of tumour origin. The hybridisation was repeated using more probe DNA in those cases in which <70% of nuclei showed a consistent result. In practice, just one of the cases reported below required a repeat hybridisation for CT4-1 in order to achieve this result.
The Two discrete signals were seen in 84% of HFF nuclei using the N-myc probe pNb-9. Nuclei from two neuroblastoma cell lines known to have amplification of N-myc were prepared. IMR32 has approximately 20 copies per cell of N-myc, while Kelly has 100 copies per cell. This produces a very characteristic picture in 90% of interphase nuclei (Figures 2 and 3) , which cannot easily be mistaken for background fluorescence. However, interphase studies will not reliably detect N-myc amplification of less than 20 copies per cell as the signal may be weak and sparsely distributed in the nucleus. Low-level amplification may be observed in neuroblastoma, but this is a rare occurrence of uncertain prognostic value. In reality, tumours with amplification of N-myc usually have a large number of copies and are easily detected by this method.
The six cases described in detail below are a representative sample chosen to show the various combinations of genomic abnormalities we most frequently observed. We are continually adding to the number of tumour samples analysed, and so far we have been able to obtain interpretable results in 93% of tumour imprints and 88% of bone marrow smears (data not shown).
FISH on tumour imprints and bone marrow smears from patients (Table I ) Case I A 3-day-old boy presented with a stage 2 abdominal neuroblastoma (Brodeur et al., 1988 (Figure 4) . The chromosome 8 centromere probe showed two populations of cells, with four copies in 45% of nuclei and three copies in 41%. These data suggest that the tumour has a complex karyotype.
Case 2 A 3-week-old boy presented with stage 4s neuroblastoma with an extensive abdominal primary and hepatic metastases. Histology was favourable. Southern blotting revealed a single copy of N-myc, but no suitable metaphases were obtained for karyotyping. Imprints made from the biopsy specimen before it was subjected to these tests were investigated. Three copies of each of the probes pUCI.77, CT4-1 and p4.4 were seen in over 70% of nuclei ( Figure 5 ), indicating that the tumour was probably triploid. There was no evidence of N-myc amplification, and in many nuclei three single copies of pNb-9 were present ( Figure 6 ). The patient was observed without therapy and the tumour regressed spontaneously. (Figure 7) . The results of the in situ hybridisation therefore correlated well with those from other techniques, showing that there was no N-myc amplification but that the tumour contained a pseudodiploid clone with a probable del(lp).
Case 4 This girl aged 7 years relapsed with bone marrow disease 5 years after diagnosis of a stage 4 neuroblastoma. A bone marrow aspirate was performed, but a solid tumour biopsy was not available. Southern blotting showed a single copy of N-myc. Karyotyping showed that there were two populations of cells, one with an apparently normal 46,XX karyotype and the other with a near-tetraploid complement of 96-97 chromosomes per cell. In many of these cells four copies of chromosome 1 were observed but the chromosome morphology was not of high quality and no definite rearrangements of lp were identified. An MGG-stained smear of the marrow aspirate showed that the neuroblastoma cells were mainly in clumps, many of them mechanically disrupted. FISH was performed directly on these preparations. The N-myc probe clearly showed two signals in most of the tumour nuclei, with no evidence of any amplified N-myc signal. Probe pUCI.77 produced four signals in 70% of the tumour nuclei, and three signals in 24%. The chromosome 8 centromere probe showed three signals in 75% of nuclei ( Figure 8 ). The distal cosmid for lp36, CT4-1, showed a maximum of three signals. These results indicated a complex karyotype, including chromosome 1 tetrasomy, with a distal lp deletion in one copy.
Case S This boy was diagnosed as having a stage 4 neuroblastoma at age 7 years and 6 months, when he presented with a primary adrenal tumour and bone marrow metastases. Both a tumour biopsy and a bone marrow aspirate were performed. Southern blotting showed that there was no amplification of N-myc. Abnormal metaphases were obtained from both the tumour and the marrow, and showed a chromosome count of 47 with several structural alterations involving chromosomes 3, 5 and 7. Additional changes in chromosomes 4 and 18 were seen only in tumour nuclei from the bone marrow. In all the metaphases studied both chromosomes 1 were grossly normal with no evidence of short-arm rearrangements. MGG staining of the marrow smears showed a heavy infiltration with tumour cells. The N-myc probe pNb-9 produced two discrete signals in many nuclei, but there was no evidence of gene amplification. Two copies both of chromosome 1 centromere and of the distal lp probe, CT4-1, were seen in approximately 90% of nuclei. The control centromere, p4.4, showed two signals in 94% of nuclei. The quality of the in situ hybridisation tended to be higher with the tumour imprints than with the marrow smears as there was less background fluorescence, and very few areas of non-tumour cells. The in situ results correlate well with the results from Southern blotting and from culturing.
Case 6 This 4-year-old girl who had previously been treated for a stage 4 neuroblastoma relapsed with a chest wall mass and axillary lymphadenopathy. Biopsies were taken from both sites and imprints were made. The results of Southern blotting revealed amplification of N-myc with approximately 20 copies. The karyotype was approximately diploid, and included an unbalanced t(l ; 1) translocation with loss of material from the distal portion of lp. Giemsa staining of slides from the chest wall and an involved lymph node showed large numbers of tumour cells, some of which were disrupted in the process of making the slides. There were two copies of pUCI.77 in over 90% of tumour nuclei (Figure 9 ), and two copies of p4.4 in 81% of nuclei. With CT4-4 only 10% of nuclei showed two signals, while the majority, 79%, showed only one signal, and a further 10% had no visible signal (Figure 10 ). The appearance after hybridisation with pNb-9 suggested a high number of copies of this probe ( Figure 1 ). The data from the in situ hybridisation therefore agreed with the karyotyping and blotting results, and showed that the tumour had both a deletion of I p and N-myc The preparation of the imprints and marrow smears, in order to make them suitable for FISH, is simple. Initially silane-coated slides were used as these increase the chance of the nuclei adhering to the slides throughout all the steps of the procedure. However, it was found that after methanolacetic acid fixation and heating there was little difference in the quality of the preparations between the two types of slide. Furthermore, spreading of aspirated bone marrow onto silane-coated slides was difficult as the liquid tended to form globules, which in turn meant that drying was a problem and that areas of cell crowding made morphological interpretation difficult. Acetic acid was chosen as a means of removing cytoplasm and debris as it is simple and quick to use, and had been found in other similar circumstances to be more effective than proteinase K or pepsin, and to allow better preservation of morphology (Hopman et al., 1989) . Another advantage of acetic acid over pepsin is that it tends to flatten the cells onto the slide, which means that fluorescent signals are more likely to be in the same plane as each other, reducing the need for refocusing (Hopman et al., 1988) . It is essential that the imprints are made as soon as possible after the biopsy is taken, as a delay of more than a few hours causes considerable deterioration in the tissue.
We have described a technique which represents a step forward in the assessment of prognosis in children with neuroblastoma. The importance of various biological factors as markers of aggressiveness of the disease has been recognised for some time, and some form of measurement of these variables has increasingly been carried out in the clinical trial setting. At present, treatment protocols are not drawn up using this information, but are still based solely on clinical prognostic factors such as age at diagnosis and stage of disease. The reasons for this are threefold. Firstly, although many biological features have been identified for neuroblastoma which relate to prognosis, no study has yet determined which are most discriminatory. The agreed goal of the International Neuroblastoma Staging System and Response Criteria Committee is to collect information on tumour histology, ploidy, N-myc gene copy number, chromosome ip deletion and serum concentrations of neuron-specific enolase, ferritin and lactate dehydrogenase for all neuroblastomas (Brodeur et al., 1993) . Analysis of these data will indicate on which biological features therapeutic decisions should be based. Secondly, the results of the investigations into N-myc amplification, ploidy and lp deletion need to be available at the time of diagnosis and commencement of treatment. Thirdly, existing methods of evaluating these biological factors require more tissue than is frequently obtained, plus expensive or specialised resources such as flow cytometry and Southern blotting, which are not readily available in all centres which are treating children with neuroblastoma. We believe that our technique comes at a time when it is appropriate to start making therapeutic decisions in neuroblastoma on the basis of biological as well as clinical factors. We also feel that this simple and immediate method can provide reliable results sufficiently quickly, at the time of diagnosis, to be useful in determining which children should receive early intensive chemotherapy. Finally, we believe that this application of FISH should become accessible to all clinicians practising in this field. The technique is simple, and, unlike complex cytogenetic and molecular biological studies, could be performed in routine service laboratories.
